Taurine transport into fetal cord blood cells: Inhibition by cyclosporine A

Paul F. Speake, Christos S. Zipitis, Angela Houston, Stephen D'Souza

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Pregnant women undergoing long-term organ transplant treatment have an increased incidence of delivering infants with intrauterine growth restriction (IUGR). Cyclosporine A is used as an immunosuppressant in such women and indirect evidence suggests that IUGR might result from an effect of cyclosporine A on amino acid transport by the placenta. In this study we tested the hypothesis that the transport of an essential amino acid, taurine, by fetal tissue other than the placenta is modulated by cyclosporine A. Cord blood cells (CBCs) were used to test this hypothesis as an easily obtainable fetal tissue. Transport of taurine into CBCs was measured using standard tracer flux assays. Uptake of [ 3H] taurine by CBCs was linear over 15 minutes (76.2 ± 16.6 fmol/10 6 cells/min, mean ± SEM, n = 6) and inhibitable by 10 mM β-alanine, a substrate of the system-β taurine transport protein (6.7 ± 1.0 fmol/10 6 cells/min, n = 6, P
    Original languageEnglish
    Pages (from-to)472-477
    Number of pages5
    JournalJournal of the Society for Gynecologic Investigation
    Volume11
    Issue number7
    DOIs
    Publication statusPublished - Oct 2004

    Keywords

    • amino acid transport
    • blood cells
    • cyclosporine A
    • Fetal
    • taurine

    Fingerprint

    Dive into the research topics of 'Taurine transport into fetal cord blood cells: Inhibition by cyclosporine A'. Together they form a unique fingerprint.

    Cite this